Left ventricular systolic and diastolic function improve after acute myocardial infarction treated with acute percutaneous coronary intervention, but are not influenced by intracoronary injection of autologous mononuclear bone marrow cells: a 3 year serial echocardiographic sub-study of the randomized-controlled ASTAMI study
Open Access
- 17 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 12 (2) , 98-106
Abstract
To clarify long-term changes in global, regional, and diastolic left ventricular (LV) function after intracoronary injection of autologous mononuclear bone marrow cells (mBMCs) in acute myocardial infarction (AMI). In the Autologous Stem cell Transplantation in Acute Myocardial Infarction (ASTAMI) study, 100 patients with anterior ST-elevation myocardial infarction and percutaneous coronary intervention on the left anterior descending artery (LAD) were randomized to receive intracoronary injection of mBMCs or not. Transthoracic echocardiography was performed at baseline, 3, 6, 12 months, and 3 years. Regional LV function was assessed by two-dimensional speckle-tracking echocardiography. From baseline to 3 years, LV ejection fraction changed from 45.7 to 47.5% in the mBMC group, and from 46.9 to 46.8% in the control group (P = 0.87 for difference in change over time between groups). Longitudinal strain in the LAD territory improved from −9.7 to −12.2% in the mBMC group and from −9.9 to −12.8% in the control group (P = 0.45). E/e′ decreased from 14.7 to 12.9 in the mBMC group and from 14.8 to 11.9 in the control group (P = 0.31). There were no significant differences between groups in change of LV volumes, global systolic function, regional function, or diastolic function during 3 years follow-up. No differences between groups indicating beneficial effect of intracoronary mBMC injection could be identified. Both groups in ASTAMI experienced improvement of global, regional, and diastolic LV function after 3–6 months, with effects sustained at 3 years.Keywords
This publication has 33 references indexed in Scilit:
- Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled studyHeart, 2009
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by EchocardiographyEuropean Heart Journal - Cardiovascular Imaging, 2008
- ReplyAmerican Heart Journal, 2008
- Anterior Myocardial Infarction With Acute Percutaneous Coronary Intervention and Intracoronary Injection of Autologous Mononuclear Bone Marrow CellsJACC, 2008
- Impact of Intracoronary Cell Therapy on Left Ventricular Function in the Setting of Acute Myocardial InfarctionJACC, 2007
- Adult Bone Marrow–Derived Cells for Cardiac RepairArchives of internal medicine (1960), 2007
- Intracoronary Injection of Mononuclear Bone Marrow Cells in Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- The consensus of the task force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for repair of the heartEuropean Heart Journal, 2006
- Recommendations for chamber quantification☆European Heart Journal - Cardiovascular Imaging, 2006
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in HumansCirculation, 2002